Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2025

TCT 638: Impact of End-Stage Renal Disease on Short- and Mid-Term Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Presenter: Mustafa Shehzad

October 26, 2025

Presentation TCT 2025

TCT 641: 5-Year Outcomes of New Generation Balloon Expandable Valve Replacement in Patients with End-Stage Renal Disease

Presenter: Hidemasa Shitan

October 26, 2025

Presentation TCT 2025

TCT 18: Divergent Mortality Trends in Aortic Stenosis by CKD Severity: A Nationwide Analysis Comparing Early-Stage Versus End-Stage Renal Disease (2010 – 2023)

Presenter: Aymen Ahmed

October 25, 2025

Presentation TCT 2024

TCT 534: Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease

Presenter: Abdullah Al-Abcha

October 27, 2024

Presentation TCT 2023

TCT 640: Trends in Patients With and Without End Stage Renal Disease Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair

Presenter: Ufuk Vardar

October 25, 2023

Presentation TCT 2023

TCT 774: Predictors of Complete Heart Block in Patients With end Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement

Presenter: Errol Moras

October 24, 2023

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

Presentation TCT 2021

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presenter: Ankur Kalra

October 20, 2021

Presentation TCT 2017

TCT 18: Feasibility, Safety, and Outcomes of Chronic Total Occlusion Revascularization in End-Stage Renal Disease

Presenter: James C. Spratt, R. Michael Wyman, Yasir Parviz, MD

October 31, 2017

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

Presentation TCT 2013

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho

January 31, 2013

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

Advertisement

TCT 638: Impact of End-Stage Renal Disease on Short- and Mid-Term Outcomes After Mitral Transcatheter Edge-to-Edge Repair

TCT 641: 5-Year Outcomes of New Generation Balloon Expandable Valve Replacement in Patients with End-Stage Renal Disease

TCT 18: Divergent Mortality Trends in Aortic Stenosis by CKD Severity: A Nationwide Analysis Comparing Early-Stage Versus End-Stage Renal Disease (2010 – 2023)

TCT 534: Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease

TCT 640: Trends in Patients With and Without End Stage Renal Disease Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair

TCT 774: Predictors of Complete Heart Block in Patients With end Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

TCT 18: Feasibility, Safety, and Outcomes of Chronic Total Occlusion Revascularization in End-Stage Renal Disease

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Preliminary Data Show Potential of Renal Denervation in Several Settings

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

More Data Needed on Renal Denervation

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content